Charles River Laboratories | الربح الإجمالي على المبيعات



Gross Profit On Sales تغيير تاريخ
Agilent USD 899M 18M 2025-01
Align Technology USD 680.11M 16.83M 2025-03
Bio-Rad Laboratories USD 310.6M 44.5M 2025-03
Bruker USD 493.3M 74.5M 2024-12
Cardinal Health USD 2.12B 182M 2025-03
Charles River Laboratories USD 319.68M 48.09M 2024-12
Cigna USD 6.61B 144M 2025-03
CVS Health USD 14.4B 1.5B 2025-03
Danaher USD 3.53B 364M 2025-03
Dentsply International USD 455M 40M 2024-12
Elevance Health 11.94B 215M 2024-12
Galapagos EUR 61.25M 98.68M 2025-03
Hologic USD 560.7M 19.8M 2025-03
Humana 3.83B 3.35B 2024-12
Illumina USD 728M 17M 2024-12
Incyte USD 985.09M 111.22M 2025-03
IQVIA Holdings USD 1.3B 80M 2025-03
Laboratory Of America USD 948M 51.7M 2025-03
Lonza CHF 1.12B 276M 2024-06
McKesson USD 3.25B 5M 2024-12
Merck EUR 3.1B 45M 2024-12
Mettler Toledo International USD 525.88M 113.44M 2025-03
Novartis USD 10.23B 294M 2024-12
Pfizer USD 11.12B 987M 2025-03
Quest Diagnostics USD 869M 11M 2025-03
Revvity USD 375.55M 36.74M 2025-03
Thermo Fisher Scientific USD 4.31B 514M 2025-03
United Therapeutics USD 701.9M 41.9M 2025-03
UnitedHealth 21.31B 1.72B 2024-12
Walgreens Boots Alliance USD 6.93B 155M 2025-02
Waters USD 384.96M 139.24M 2025-03
West Pharmaceutical Services USD 231.9M 41.7M 2025-03



Charles River Laboratories الربح الإجمالي على المبيعات - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - May 2025.